▲Celemix CI
It has been confirmed that Celemics can analyze the ‘stealth omicron’, which cannot be caught even by PCR test, with its genome analysis technology. Celemix is the only gene targeting kit company in Europe, Asia, and the Middle East and has only 6 companies worldwide, and is also supplying it to the Korea Centers for Disease Control and Prevention.
On the 9th, a Celemics official said, “Coronavirus infection (COVID-19) mutations are occurring continuously.
He added, “Stealth Omicron can also be detected as a mutation by genome analysis.”
As the new mutant omicron of Corona 19 is spreading around the world, the world is nervous about the discovery of a ‘stealth micron’ that cannot be filtered by PCR test.
According to the World Health Organization (WHO), Omicron is tracking cases where ‘SGTF (S gene target faillure)’ appears as a result of PCR testing of samples from confirmed patients. Stealth Omicron revealed that it is difficult to detect because it does not fail to target the S gene even though it is similar to the existing Omicron.
Experts have already classified the Stealth Omicron as a ‘new subfamily’ of the existing Omicron. However, if the stealth Omicron is found to be more genetically different from the existing Omicron, it is expected to be classified as a different mutant strain.
On the news of the discovery of stealth Omicron, which cannot be detected even by PCR test, diagnostic kit-related stocks such as Seegene, Labgenomics, and SD Biotechnology are showing weakness in the stock market. This is because of concerns that existing diagnostic kits may become useless.
In Asia, Europe, and the Middle East, the target capture kit, which is the main product line of Celekmix, can be manufactured only by Celemix, and 6 companies around the world are manufacturing and supplying it. Six companies, including Celemics, have an oligopoly of 95% of the global market.
A Celemics official said, “We have been continuously catching Corona 19 mutant viruses such as delta mutations. “He said.
.
